BioBridgeXAll companies

Cellectar Biosciences, Inc.

Pharmaceutical company · Florham Park, New Jersey, United States · Nasdaq: CLRB

Cellectar Biosciences, Inc. is a pharmaceutical company headquartered in Florham Park, New Jersey, United States. Its shares trade on Nasdaq under the ticker CLRB. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $6.1 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2023.

www.cellectar.comProfile compiled from public records. Is this your company? Request a correction or update

Cellectar Biosciences at a glance

Typepharmaceutical company
HeadquartersFlorham Park, New Jersey, United States
Stock listingNasdaq: CLRB
SEC industryPharmaceutical Preparations
Employees (per SBIR records)25
SEC CIK1279704

What does Cellectar Biosciences do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $6.1 million in total (2007 to 2022). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

9 Form D notices; the most recent reported $24.5 million sold (2023).

Frequently asked questions about Cellectar Biosciences

Where is Cellectar Biosciences headquartered?

Cellectar Biosciences, Inc. is headquartered in Florham Park, New Jersey, United States.

What does Cellectar Biosciences do?

Cellectar Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Cellectar Biosciences a public company?

Yes. Cellectar Biosciences, Inc. trades on Nasdaq under the ticker CLRB.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.